Finoriq research workspace
ACCURAY INC (ARAY) SEC Filings & Filing Highlights
Accuray Incorporated engages in the design, development, manufacture, and sale of radiosurgery. Review ARAY SEC filings, filing highlights, and disclosure activity on Finoriq.
Company Snapshot
Accuray Incorporated engages in the design, development, manufacture, and sale of radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. The company offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. It also provides the TomoTherapy platform, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, the company offers post-contract customer support, installation, training, and other professional services. It primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.
- Company
- ACCURAY INC (ARAY)
- Ticker
- ARAY
- Market Cap
- $29.8M
- Latest Price
- $0.2505
- Industry
- Medical Devices
ACCURAY INC (ARAY) Recent SEC Filing Highlights
Recent SEC filings, filing events, and disclosure highlights indexed for ACCURAY INC (ARAY).
| Event | Form | Date |
|---|---|---|
| ACCURAY INCORPORATEDOn June 1, 2026, the Company retired the Notes in accordance with their terms. The Company repaid the remaining outstanding aggregate princ... | 8-K7.01 | 2026-06-04 |
| ACCURAY INC: Agreement terminationOn June 1, 2026, the remaining outstanding aggregate principal amount of 3.75% Convertible Senior Notes due 2026 (the “Notes”) issued by Ac... | 8-K1.02 | 2026-06-04 |
| The furnishing of the attached presentation is not an admission as to the materiality of any in...The furnishing of the attached presentation is not an admission as to the materiality of any information therein. The information contained... | 8-K7.01 | 2026-05-06 |
| ACCURAY INC: Earnings or resultsOn May 6, 2026, the Company issued a press release announcing its financial results for the third quarter ended March 31, 2026, and the wit... | 8-K2.02 | 2026-05-06 |
| (b) Leonel Peralta, Senior Vice President, Chief Operations Officer of Accuray Incorporated (th...(b) Leonel Peralta, Senior Vice President, Chief Operations Officer of Accuray Incorporated (the “Company”), departed from the Company effe... | 8-K5.02 | 2026-04-28 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.